enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA says Lilly’s weight-loss drug shortage is resolved

   www.aol.com/news/us-fda-says-lilly-weight...

   A Lilly spokesperson said anyone marketing or selling unapproved versions of tirzepatide, the chemical name for its weight-loss drug Zepbound and diabetes medicine Mounjaro, must now stop and ...

3. FDA finalizes decision to end Lilly's GLP-1 shortage ... - AOL

   www.aol.com/finance/fda-finalizes-decision-end...

   The Food and Drug Administration has finalized its decision to call an end to the drug shortage of Eli Lilly's blockbuster GLP-1 products, often referred to by their formula name, tirzepatide.Eli ...

4. FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no ...

   www.aol.com/news/fda-weight-loss-drug-zepbound...

   A Lilly spokesperson said anyone marketing or selling unapproved versions of tirzepatide must now stop and begin transitioning patients to FDA-approved medicines.

5. Lilly CEO says weight-loss drug shortage to end 'very soon ...

   www.aol.com/news/lilly-ceo-says-weight-loss...

   Lilly's drug, tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management, will cease to be in shortage "very soon," CEO David Ricks said in an interview with Bloomberg in Paris.

6. Off-brand versions of Lilly weight loss drug must be pulled ...

   www.aol.com/news/off-brand-versions-lilly-weight...

   On Dec. 19, the FDA said off-brand versions of the Eli Lilly wight loss drug must be pulled off the market. ... including semaglutide and tirzepatide, as an option for weight loss," the FDA said ...

7. FDA keeps Mounjaro off shortage list after reevaluation - AOL

   www.aol.com/fda-keeps-mounjaro-off-shortage...

   In a statement to The Hill, a Lilly spokesperson said, “FDA’s decision today, reiterating that the tirzepatide shortage is resolved, reflects the tireless work of our manufacturing and quality ...

8. Tirzepatide - Wikipedia

   en.wikipedia.org/wiki/Tirzepatide

   Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes [10] [13] [14] [15] and for weight loss. [11] [16] Tirzepatide is administered via subcutaneous injections (under the skin). [10] [13] It is sold under the brand name Mounjaro for diabetes treatment, [10] and Zepbound for weight loss and treatment of obstructive ...

9. Eli Lilly's tirzepatide cuts heart failure risks, company says

   www.aol.com/news/eli-lillys-tirzepatide-cuts...

   Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.